首页 >
法规速递
-
国家药监局药审中心关于发布《罕见疾病药物开发中疾病自然史研究指导原则》的通告（2023年第43号）-2023/7/27
2023-07-28查看详情 > -
国家药监局关于修订祖卡木制剂、金刚藤制剂和斑秃丸说明书的公告（2024年第11号）-2024/2/6
2024-03-11查看详情 > -
Document: Member states contact points for translations review-2025/1/31
2025-02-05查看详情 > -
Document: European Shortages Monitoring Platform (ESMP) Application Programming Interface (API) specifications-2025/3/10
2025-03-11查看详情 > -
Document: Minutes - PDCO minutes of the 25-28 February 2025 meeting-2025/4/10
2025-04-11查看详情 > -
Document: Overview of comments received on ICH E6(R3) guideline for good clinical practice – Annex 2 - Step 2b-2025/5/23
2025-05-26查看详情 > -
Page: Requesting scientific advice or protocol assistance from EMA-2025/6/30
2025-07-01查看详情 > -
Page: EudraVigilance: electronic reporting-2025/7/30
2025-07-31查看详情 > -
Document: Overview of Network Data Steering Group (NDSG) change management activities 2025-2026-2025/9/18
2025-09-19查看详情 > -
Document: Annex IV - Discussion meeting with applicant - molecule-independent device bridging approach (MIDBA)-2025/10/24
2025-10-27查看详情 >
